US FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQTUc2eVR1WE9TcDg4dEExTjhvcXRBenlRM3lLZUlaS19BUU1OZWk0dVVGWWUzSk5nUWtBYXI5bUNTd3R2UU5yWTN2bS1oaGZ6ZlczU3c3aGhGTFFCbFVDcFdmNWwtbkRLU0ZRaTc1T25TQUpkVEdxRWFTLVYxVENZbmtIZU9mSTZ0VzFaUy1iLW1jeGd1M2hPeVJkT3ZweGFzOHpLT2tkVG1qRlV3THFKVQ?oc=5" target="_blank">US FDA approves Roivant-Priovant's skin and muscle disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMChina approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
August 28, 2026 at 06:38 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AM